ABOUT

ISSUE

SUPPORT

PATIENT SAFETY

NEWSROOM

RESOURCES

GET INVOLVED

ABOUT

ISSUE

SUPPORT

PATIENT SAFETY

NEWSROOM

RESOURCES

ABOUT

ISSUE

SUPPORT

PATIENT SAFETY

NEWSROOM

RESOURCES

GET INVOLVED

Newsroom

Newsroom

Newsroom

ALL POSTS

PRESS RELEASES

Oct 15, 2026

Black Mold, Bugs Found at Chinese Plants Making GLP-1 Compounding Agents

Oct 7, 2026

Exclusive — RX Border Defense’s Dr. Michael Burgess: Obsolete FDA ‘Green List’ Allowing Illicit Chinese Ingredients for Compounded GLP-1s into U.S.

Aug 24, 2026

Op-Ed: How The FDA’s Green List For GLP-1 Drugs Fuels The Gray Market Problem

Aug 5, 2026

Michigan Man Sentenced to 21 Months in Federal Peptide and GLP-1 Drug Case

ALL POSTS

PRESS RELEASES

Oct 15, 2026

Black Mold, Bugs Found at Chinese Plants Making GLP-1 Compounding Agents

Oct 7, 2026

Exclusive — RX Border Defense’s Dr. Michael Burgess: Obsolete FDA ‘Green List’ Allowing Illicit Chinese Ingredients for Compounded GLP-1s into U.S.

Aug 24, 2026

Op-Ed: How The FDA’s Green List For GLP-1 Drugs Fuels The Gray Market Problem

Aug 5, 2026

Michigan Man Sentenced to 21 Months in Federal Peptide and GLP-1 Drug Case

RX Border Defense is a 501(c)(4) nonprofit organization.


ABOUT

ISSUE

PATIENT SAFETY

SUPPORT

GET INVOLVED

NEWSROOM

RESOURCES

© 2026 RX Border Defense. All rights reserved.

RX Border Defense is a 501(c)(4) nonprofit organization.


ABOUT

ISSUE

PATIENT SAFETY

SUPPORT

GET INVOLVED

NEWSROOM

RESOURCES

© 2026 RX Border Defense. All rights reserved.

RX Border Defense is a 501(c)(4) nonprofit organization.


ABOUT

ISSUE

PATIENT SAFETY

SUPPORT

GET INVOLVED

NEWSROOM

RESOURCES

© 2026 RX Border Defense. All rights reserved.